Medication:

Durvalumab (1120 mg iv every 3 weeks)

Pattern:

Mixed initially (R=2.3), cholestatic thereafter (R=0.6 to 1.6)

Severity:

1+ (liver enzyme elevations without jaundice)

Latency:

4 months

Recovery:

4-6 months

Other medications:

None mentioned

From: Durvalumab

Cover of LiverTox
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.